| Q97651384 | A Randomized Controlled Study to Evaluate the Safety and Reactogenicity of a Novel rVLP-Based Plant Virus Nanoparticle Adjuvant Combined with Seasonal Trivalent Influenza Vaccine Following Single Immunization in Healthy Adults 18-50 Years of Age |
| Q37578458 | A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant |
| Q52607180 | A Respiratory Syncytial Virus vaccine based on the Small Hydrophobic protein ectodomain presented with a novel lipid-based formulation is highly immunogenic and safe in adults: a first-in-humans study. |
| Q30227026 | A composite epidemic curve for seasonal influenza in Canada with an international comparison |
| Q45382330 | A dose-ranging study of a subunit Respiratory Syncytial Virus subtype A vaccine with and without aluminum phosphate adjuvantation in adults > or =65 years of age. |
| Q57793570 | A double-blind, randomized phase II trial of the safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adults |
| Q57793204 | A global prescription for adult immunization: Time is catching up with us |
| Q47685092 | A pilot study to quantify parental anxiety associated with enrollment of an infant or toddler in a phase III vaccine trial |
| Q39567454 | A randomized control trial comparing immunogenicity, safety, and preference for self- versus nurse-administered intradermal influenza vaccine |
| Q30422975 | A randomized, controlled non-inferiority trial comparing A(H1N1)pmd09 vaccine antigen, with and without AS03 adjuvant system, co-administered or sequentially administered with an inactivated trivalent seasonal influenza vaccine |
| Q35887631 | A universal infant rotavirus vaccine program in two delivery models: Effectiveness and adverse events following immunization |
| Q35887486 | Against vaccine assay secrecy |
| Q40467229 | An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vacc |
| Q89699871 | Antimicrobial use among adult inpatients at hospital sites within the Canadian Nosocomial Infection Surveillance Program: 2009 to 2016 |
| Q37713784 | Assessing the risk of intussusception and rotavirus vaccine safety in Canada |
| Q33818337 | Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial |
| Q91595412 | Birth by Caesarean section and otitis media in childhood: a retrospective cohort study |
| Q37736017 | Canada's National Advisory Committee on Immunization (NACI): evidence-based decision-making on vaccines and immunization |
| Q57794043 | Canadian Acute Respiratory Illness and Flu Scale (CARIFS) |
| Q30908209 | Characteristics and outcome of infants with candiduria in neonatal intensive care - a Paediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study |
| Q51119248 | Co-morbidities associated with influenza-attributed mortality, 1994-2000, Canada. |
| Q57794321 | Commentary: Waterless hand hygiene&OV0093;if there’s a will, there’s a way |
| Q45359735 | Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in health |
| Q37600163 | Comparison of the Safety and Immunogenicity of a Novel Quadrivalent Meningococcal ACWY-Tetanus Toxoid Conjugate Vaccine and a Marketed Quadrivalent Meningococcal ACWY-Diphtheria Toxoid Conjugate Vaccine in Healthy Individuals 10-25 Years of Age. |
| Q57793454 | Comparison of the safety and immunogenicity of concomitant and sequential administration of an adult formulation tetanus and diphtheria toxoids adsorbed combined with acellular pertussis (Tdap) vaccine and trivalent inactivated influenza vaccine in a |
| Q45423583 | Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults |
| Q41578602 | Complete Sequence of Four Multidrug-Resistant MOBQ1 Plasmids Harboring blaGES-5 Isolated from Escherichia coli and Serratia marcescens Persisting in a Hospital in Canada |
| Q57792787 | Corrigendum to “Immunological priming induced by a two-dose series of H5N1 influenza antigen, administered alone or in combination with two different formulations of AS03 adjuvant in adults: Results of a randomised single heterologous booster dose |
| Q33637512 | Cost-effectiveness of alternate strategies for childhood immunization against meningococcal disease with monovalent and quadrivalent conjugate vaccines in Canada |
| Q40554549 | Coxiella burnetii seropositivity in parturient women is associated with adverse pregnancy outcomes |
| Q36109285 | Defining pneumonia in critically ill infants and children |
| Q36109236 | Defining urinary tract infection in the critically ill child |
| Q57794219 | Demand for isolation beds in a pediatric hospital☆ |
| Q43914636 | Development and validation of a risk scoring tool to predict respiratory syncytial virus hospitalization in premature infants born at 33 through 35 completed weeks of gestation |
| Q53187746 | Differences in efficiency, satisfaction and adverse events between self-administered intradermal and nurse-administered intramuscular influenza vaccines in hospital workers. |
| Q30403078 | Dose-sparing H5N1 A/Indonesia/05/2005 pre-pandemic influenza vaccine in adults and elderly adults: a phase III, placebo-controlled, randomized study |
| Q57792382 | Early Onset Invasive Candidiasis in Extremely Low Birth Weight Infants: Perinatal Acquisition Predicts Poor Outcome |
| Q43835309 | Economic evaluation of respiratory syncytial virus infection in Canadian children: a Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study |
| Q37131005 | Economic evaluation of vaccines in Canada: A systematic review |
| Q90926895 | Effectiveness of Influenza Vaccination on Hospitalizations and Risk Factors for Severe Outcomes in Hospitalized Patients With COPD |
| Q40835658 | Efficacy of antimicrobial prophylaxis in placement of cerebrospinal fluid shunts: meta-analysis. |
| Q37124705 | Elevated inflammatory mediators in adults with oculorespiratory syndrome following influenza immunization: a public health agency of Canada/Canadian Institutes of Health Research Influenza Research Network Study |
| Q33371823 | Empyema associated with community-acquired pneumonia: a Pediatric Investigator's Collaborative Network on Infections in Canada (PICNIC) study |
| Q39813672 | Estimating Respiratory Syncytial Virus-associated Hospitalization in the First Year of Life Among Infants Born at 32-35 Weeks of Gestation |
| Q30227634 | Estimating sensitivity of laboratory testing for influenza in Canada through modelling |
| Q35947501 | Evaluation of a tuberculosis screening program at a children's hospital |
| Q30397802 | Evaluation of adjuvanted pandemic H1N1(2009) influenza vaccine after one and two doses in young children |
| Q96341204 | Evaluation of the protective potential of antibody and T cell responses elicited by a novel preventative vaccine towards respiratory syncytial virus small hydrophobic protein |
| Q51367226 | Factors associated with influenza vaccination among healthcare workers in acute care hospitals in Canada. |
| Q58866004 | Frailty Hinders Recovery From Acute Respiratory Illness in Older Adults |
| Q57793117 | Health Care–Associated Infection in the Pediatric Intensive Care Unit |
| Q54716469 | Health care epidemiology perspective on the October 2006 recommendations of the Subcommittee on Diagnosis and Management of Bronchiolitis. |
| Q44023221 | Health-associated infections in a pediatric nephrology unit in China |
| Q40981809 | Healthcare-Associated Clostridium difficile Infections and Strain Diversity in Pediatric Hospitals in the Canadian Nosocomial Infection Surveillance Program, 2007-2011. |
| Q45762323 | Hepatitis A and travel amongst Nova Scotia postsecondary students: evidence for a targeted vs. universal immunization strategy |
| Q35039077 | Highlights of the National Advisory Committee on Immunization statement on influenza for the 2006-2007 season |
| Q57706344 | Hospitalization Attributable to Influenza and Other Viral Respiratory Illnesses in Canadian Children |
| Q37996090 | Human challenge studies: a review of adequacy of reporting methods and results |
| Q57794423 | Immune Responses to Pertussis Vaccines Concurrently Administered with Viral Vaccines |
| Q38480589 | Immune responses in adults to revaccination with a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine 10 years after a previous dose |
| Q57104857 | Immunization: a global challenge for the 21st Century |
| Q36009631 | Immunogenicity and Reactogenicity of an Inactivated Quadrivalent Influenza Vaccine Administered Intramuscularly to Children 6 to 35 Months of Age in 2012-2013: A Randomized, Double-Blind, Controlled, Multicenter, Multicountry, Clinical Trial |
| Q36851155 | Immunogenicity and Safety of 2 Dose Levels of a Thimerosal-Free Trivalent Seasonal Influenza Vaccine in Children Aged 6-35 Months: A Randomized, Controlled Trial |
| Q39350694 | Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants |
| Q37037095 | Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in children |
| Q34342056 | Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial |
| Q38392949 | Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial. |
| Q44781098 | Immunogenicity of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in nonresponders to licensed hepatitis B vaccine |
| Q42178340 | Immunogenicity of heterologous H5N1 influenza booster vaccination 6 or 18 months after primary vaccination in adults: a randomized controlled clinical trial |
| Q30226579 | Immunological priming induced by a two-dose series of H5N1 influenza antigen, administered alone or in combination with two different formulations of AS03 adjuvant in adults: results of a randomised single heterologous booster dose study at 15 month |
| Q47097706 | Impact of Antivirals in the Prevention of Serious Outcomes Associated with Influenza in Hospitalized Canadian Adults: A Pooled Analysis from the Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN). |
| Q34196755 | Implementation of a universal rotavirus vaccination program: comparison of two delivery systems |
| Q37386258 | Improving the quality of care for infants: a cluster randomized controlled trial |
| Q48482247 | In memoriam, Bernard Duval (1949-2008). |
| Q38232817 | Incorporating economic evaluation into immunization decision making in Canada: a workshop |
| Q51641779 | Increasing incidence of hospitalization for bronchiolitis among Canadian children, 1980-2000. |
| Q57793324 | Influenza |
| Q36069584 | Influenza and the influenza vaccine |
| Q47137946 | Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in Canada |
| Q52651633 | Influenza vaccine effectiveness to prevent influenza-related hospitalizations and serious outcomes in Canadian adults over the 2011/12 through 2013/14 influenza seasons: A pooled analysis from the Canadian Immunization Research Network (CIRN) Seriou |
| Q57706328 | Influenza-attributable deaths, Canada 1990-1999 |
| Q51104978 | Influenza-attributed hospitalization rates among pregnant women in Canada 1994-2000. |
| Q40484747 | Interchangeability of two diphtheria and tetanus toxoids, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate vaccines as a fourth dose in 15-20-month-old toddlers |
| Q33777640 | Invasive candidiasis in low birth weight preterm infants: risk factors, clinical course and outcome in a prospective multicenter study of cases and their matched controls |
| Q57793146 | Kinetics of the Antibody Response to Tetanus-Diphtheria-Acellular Pertussis Vaccine in Women of Childbearing Age and Postpartum Women |
| Q40440945 | Knowledge, attitudes, beliefs, and behaviors of parents and healthcare providers before and after implementation of a universal rotavirus vaccination program |
| Q37130808 | Knowledge, attitudes, beliefs, and behaviors of pregnant women approached to participate in a Tdap maternal immunization randomized, controlled trial |
| Q40271669 | Knowledge, attitudes, beliefs, and behaviors of university students, faculty, and staff during a meningococcal serogroup B outbreak vaccination program. |
| Q46622417 | Meeting Report: Harmonization of RSV therapeutics – from design to performance |
| Q64360571 | Motivation for participating in phase 1 vaccine trials: Comparison of an influenza and an Ebola randomized controlled trial |
| Q44687965 | National surveillance of methicillin-resistant Staphylococcus aureus among hospitalized pediatric patients in Canadian acute care facilities, 1995-2007. |
| Q57793643 | Nosocomial Infections in the Pediatric Intensive Care Unit: Epidemiology and Control |
| Q36814797 | Optimizing the delivery and use of a new monoclonal antibody in children with congenital heart disease: a successful provincial respiratory syncytial virus prophylaxis program |
| Q33239318 | Paediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of aseptic meningitis |
| Q50588783 | Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of admission and management variation in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. |
| Q50963236 | Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulations. |
| Q57793536 | Phase 1 first-in-human studies of the reactogenicity and immunogenicity of a recombinant meningococcal NspA vaccine in healthy adults |
| Q30424199 | Pilot-testing an applied competency-based approach to health human resources planning |
| Q30986191 | Pneumococcal and influenza immunization in asplenic persons: a retrospective population-based cohort study 1990-2002. |
| Q35943670 | Prevention of influenza in the general population |
| Q37596393 | Prevention of influenza in the general population: recommendation statement from the Canadian Task Force on Preventive Health Care |
| Q37721415 | Prospects for defined epitope vaccines for respiratory syncytial virus |
| Q24810199 | Racemic epinephrine compared to salbutamol in hospitalized young children with bronchiolitis; a randomized controlled clinical trial [ISRCTN46561076]. |
| Q30419230 | Randomized, multicenter trial of a single dose of AS03-adjuvanted or unadjuvanted H1N1 2009 pandemic influenza vaccine in children 6 months to <9 years of age: safety and immunogenicity |
| Q39683218 | Rapid surveillance for health events following a mass meningococcal B vaccine program in a university setting: A Canadian Immunization Research Network study |
| Q38581057 | Reducing infection transmission in the playroom: Balancing patient safety and family-centered care |
| Q36069587 | Release of the statement on influenza for the 2007 2008 season from the National Advisory Committee on Immunization |
| Q40353062 | Reply to Weber, von Cube, Sommer, Wolkewitz: Necessity of a Competing Risk Approach in Risk Factor Analysis of Central-Line-Associated Bloodstream Infection |
| Q52891063 | Report on the 1st international workshop on procedures for the development of evidence-based vaccination recommendations, Berlin, Germany, 22-23 November 2010. |
| Q35037404 | Respiratory syncytial virus-associated intensive care unit admission in children in Southern China |
| Q37358700 | Results from the Canadian Nosocomial Infection Surveillance Program on Carbapenemase-Producing Enterobacteriaceae, 2010 to 2014. |
| Q36703357 | Review: antiviral agents reduce the risk of influenza in healthy adults and alleviate symptoms faster than placebo |
| Q39800253 | Risk Factors for Central Venous Catheter-Associated Bloodstream Infection in Pediatric Patients: A Cohort Study |
| Q36251834 | Role of influenza and other respiratory viruses in admissions of adults to Canadian hospitals |
| Q37135000 | Routine immunization of adults by pharmacists: Attitudes and beliefs of the Canadian public and health care providers. |
| Q57793012 | Safety and Immunogenicity of 2 Mixed Primary Infant Immunization Schedules of Pentavalent Diphtheria, Tetanus, Acellular Pertussis, Inactivated Poliomyelitis, and Haemophilus influenzae Type b Vaccines at 2, 4, and 6 Months of Age |
| Q30227196 | Safety and cross-reactive immunogenicity of candidate AS03-adjuvanted prepandemic H5N1 influenza vaccines: a randomized controlled phase 1/2 trial in adults |
| Q30414902 | Safety and immunogenicity of 2010-2011 H1N12009-containing trivalent inactivated influenza vaccine in children 12-59 months of age previously given AS03-adjuvanted H1N12009 pandemic vaccine: a PHAC/CIHR Influenza Research Network (PCIRN) study |
| Q40498619 | Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers |
| Q57793703 | Safety and immunogenicity of a Proteosome™-trivalent inactivated influenza vaccine, given nasally to healthy adults |
| Q57793040 | Safety and immunogenicity of different two-dose regimens of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in healthy young adults |
| Q57794511 | Sepsis in febrile neutropenic children with cancer |
| Q57793163 | Serratia marcescens outbreak in a neonatal intensive care unit related to the exit port of an oscillator |
| Q57794149 | Seven Days of Erythromycin Estolate Is as Effective as Fourteen Days for the Treatment of Bordetella pertussis Infections |
| Q45128775 | Severe combined immunodeficiency (SCID) in Canadian children: a national surveillance study |
| Q43274706 | Splenectomy: reducing the risk of infection |
| Q30406834 | Strategies for successful rapid trials of influenza vaccine |
| Q57793360 | Study of Cerebrospinal Fluid Shunt–Associated Infections in the First Year Following Placement, by the Canadian Nosocomial Infection Surveillance Program |
| Q50588827 | Study of interobserver reliability in clinical assessment of RSV lower respiratory illness: a Pediatric Investigators Collaborative Network for Infections in Canada (PICNIC) study. |
| Q57792424 | The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People |
| Q35884560 | The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation |
| Q99604747 | The Power of First Impressions: Can Influenza Imprinting during Infancy Inform Vaccine Design? |
| Q36120473 | The challenge of vaccinating adults: attitudes and beliefs of the Canadian public and healthcare providers. |
| Q30404598 | The geographic synchrony of seasonal influenza: a waves across Canada and the United States |
| Q35009232 | The role of Clostridium difficile and viruses as causes of nosocomial diarrhea in children |
| Q40515719 | The role of healthcare provider attitudes in increasing willingness to accept seasonal influenza vaccine policy changes |
| Q40316729 | Tolerability and antibody response in adolescents and adults revaccinated with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed (Tdap) 4-5 years after a previous dose |
| Q28067058 | Toward Standardizing a Lexicon of Infectious Disease Modeling Terms |
| Q48316344 | Type III hypersensitivity reactions to a B cell epitope antigen are abrogated using a depot forming vaccine platform |
| Q45134307 | Unique epidemiology of nosocomial urinary tract infection in children |
| Q36256236 | Universal tetanus, diphtheria, acellular pertussis (Tdap) vaccination of adults: What Canadian health care providers know and need to know. |
| Q57794541 | Validation of croup scoring methods 694 |
| Q33756649 | Variable morbidity of respiratory syncytial virus infection in patients with underlying lung disease: a review of the PICNIC RSV database. Pediatric Investigators Collaborative Network on Infections in Canada. |
| Q40774953 | Variation in risk for nosocomial chickenpox after inadvertent exposure. |